By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – HealthLinx today said that Seoul Clinical Laboratories will distribute the firm's OvPlex diagnostic panel in South Korea.

SCL will begin distribution of the protein biomarkers-based test once it has received marketing approval from the South Korea Food and Drug Administration. HealthLinx said it is conducting a 220-patient study aimed at supporting its marketing application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.